For the quarter ending 2026-03-31, SINT had -$4,903K decrease in cash & cash equivalents over the period. $3,872K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Impairment of armor | -64 | 0 | 64 |
| Loss on disposal of subsidiary | 0 | - | - |
| Stock based compensation - non-employee | -606 | 342 | 264 |
| Other liabilities | -34 | -750 | 784 |
| Net loss | 5,328 | -3,539 | -4,610 |
| Depreciation expense | -177 | 74 | 171 |
| Amortization of right of use asset | -166 | 77 | 169 |
| Loss on disposal of subsidiary | - | 0 | 25 |
| Amortization of intangible assets | -3 | 8 | 3 |
| Loss (gain) on disposal of equipment | - | 0 | 352 |
| Stock based compensation - employee | -209 | 546 | 193 |
| Change in fair value of derivative liabilities | 509 | -214 | 48 |
| Bad debt (recoveries) expense | 10 | 2 | -3 |
| Trade accounts receivable | 182 | 25 | -12 |
| Prepaid expenses and other current assets | 122 | -200 | 130 |
| Inventories | 459 | 43 | -153 |
| Accounts payable and accrued liabilities | 412 | 464 | -217 |
| Payments on operating lease liability | 190 | -87 | -188 |
| Net cash used in operating activities | 3,736 | -2,517 | -3,710 |
| Proceeds from acquisition of sinaptic surgical | - | 750 | - |
| Proceeds from notes receivable, net of imputed interest | - | - | 0 |
| Proceeds from sale of property and equipment | - | 0 | 352 |
| Disposal of property and equipment, net of cash received | -4 | 0 | 4 |
| Purchase of property and equipment | -136 | 84 | 59 |
| Proceeds from issuance of warrant derivative liabilities | - | - | 0 |
| Net cash used in investing activities | -962 | 666 | 289 |
| Proceeds from issuance of common stock and prefunded warrants, net of cash fees | -4,380 | 1 | 4,379 |
| Proceeds from exercise of warrants, net of cash fees, and deposit for stock issuance (in other current liabilities) | - | 3,624 | - |
| Purchase of common stock into treasury | -133 | 0 | 133 |
| Proceeds from issuance of warrants in connection with exercise of warrants | - | 206 | - |
| Proceeds from issuance of common stock in connection with atm, net of fees | 266 | - | - |
| Proceeds from issuance of common stock in connection with exercise of warrants | - | - | 0 |
| Payments on debt | -134 | 50 | 103 |
| Net cash provided by financing activities | -7,677 | 3,781 | 4,143 |
| Net increase (decrease) in cash and cash equivalents | -4,903 | - | - |
| Net increase (decrease) in cash and cash equivalents | -4,903 | 1,930 | 722 |
| Cash and cash equivalents at beginning of period | 6,250 | 3,598 | - |
| Cash and cash equivalents at end of period | 1,889 | 6,250 | - |
Sintx Technologies, Inc. (SINT)
Sintx Technologies, Inc. (SINT)